Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype

ABSTRACT:

SUBMITTER: Ning X 

PROVIDER: S-EPMC12928570 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature